Literature DB >> 29691280

A Transcriptional Regulatory Network Containing Nuclear Receptors and Long Noncoding RNAs Controls Basal and Drug-Induced Expression of Cytochrome P450s in HepaRG Cells.

Liming Chen1, Yifan Bao1, Stephanie C Piekos1, Kexin Zhu1, Lirong Zhang1, Xiao-Bo Zhong2.   

Abstract

Cytochrome P450 (P450) enzymes are responsible for metabolizing drugs. Expression of P450s can directly affect drug metabolism, resulting in various outcomes in therapeutic efficacy and adverse effects. Several nuclear receptors are transcription factors that can regulate expression of P450s at both basal and drug-induced levels. Some long noncoding RNAs (lncRNAs) near a transcription factor are found to participate in the regulatory functions of the transcription factors. The aim of this study is to determine whether there is a transcriptional regulatory network containing nuclear receptors and lncRNAs controlling both basal and drug-induced expression of P450s in HepaRG cells. Small interfering RNAs or small hairpin RNAs were applied to knock down four nuclear receptors [hepatocyte nuclear factor 1α (HNF1α), hepatocyte nuclear factor 4α (HNF4α), pregnane X receptor (PXR), and constitutive androstane receptor (CAR)] as well as two lncRNAs [HNF1α antisense RNA 1 (HNF1α-AS1) and HNF4α antisense RNA 1 (HNF4α-AS1)] in HepaRG cells with or without treatment of phenobarbital or rifampicin. Expression of eight P450 enzymes was examined in both basal and drug-induced levels. CAR and PXR mainly regulated expression of specific P450s. HNF1α and HNF4α affected expression of a wide range of P450s as well as other transcription factors. HNF1α and HNF4α controlled the expression of their neighborhood lncRNAs, HNF1α-AS1 and HNF4α-AS1, respectively. HNF1α-AS1 and HNF4α-AS1 was also involved in the regulation of P450s and transcription factors in diverse manners. Altogether, our study concludes that a transcription regulatory network containing the nuclear receptors and lncRNAs controls both basal and drug-induced expression of P450s in HepaRG cells.
Copyright © 2018 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29691280      PMCID: PMC5988030          DOI: 10.1124/mol.118.112235

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  53 in total

1.  Interaction of noncoding RNA with the rDNA promoter mediates recruitment of DNMT3b and silencing of rRNA genes.

Authors:  Kerstin-Maike Schmitz; Christine Mayer; Anna Postepska; Ingrid Grummt
Journal:  Genes Dev       Date:  2010-10-15       Impact factor: 11.361

2.  Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses.

Authors:  Moran N Cabili; Cole Trapnell; Loyal Goff; Magdalena Koziol; Barbara Tazon-Vega; Aviv Regev; John L Rinn
Journal:  Genes Dev       Date:  2011-09-02       Impact factor: 11.361

3.  Long non-coding RNA HNF1A-AS1 promotes hepatocellular carcinoma cell proliferation by repressing NKD1 and P21 expression.

Authors:  Cong Wang; Lin Mou; Hai-Xia Chai; Feng Wang; Yun-Zhi Yin; Xiao-Yu Zhang
Journal:  Biomed Pharmacother       Date:  2017-03-08       Impact factor: 6.529

Review 4.  Long noncoding RNAs: cellular address codes in development and disease.

Authors:  Pedro J Batista; Howard Y Chang
Journal:  Cell       Date:  2013-03-14       Impact factor: 41.582

5.  Role of the hepatocyte nuclear factor 4alpha in control of the pregnane X receptor during fetal liver development.

Authors:  Akihide Kamiya; Yusuke Inoue; Frank J Gonzalez
Journal:  Hepatology       Date:  2003-06       Impact factor: 17.425

6.  Functional inhibitory cross-talk between constitutive androstane receptor and hepatic nuclear factor-4 in hepatic lipid/glucose metabolism is mediated by competition for binding to the DR1 motif and to the common coactivators, GRIP-1 and PGC-1alpha.

Authors:  Ji Miao; Sungsoon Fang; Yangjin Bae; Jongsook Kim Kemper
Journal:  J Biol Chem       Date:  2006-02-21       Impact factor: 5.157

7.  The orphan nuclear receptor HNF4alpha determines PXR- and CAR-mediated xenobiotic induction of CYP3A4.

Authors:  Rommel G Tirona; Wooin Lee; Brenda F Leake; Lu-Bin Lan; Cynthia Brimer Cline; Vishal Lamba; Fereshteh Parviz; Stephen A Duncan; Yusuke Inoue; Frank J Gonzalez; Erin G Schuetz; Richard B Kim
Journal:  Nat Med       Date:  2003-01-06       Impact factor: 53.440

Review 8.  Mechanisms of cytochrome P450 induction.

Authors:  Leslie M Tompkins; Andrew D Wallace
Journal:  J Biochem Mol Toxicol       Date:  2007       Impact factor: 3.642

Review 9.  Neighboring gene regulation by antisense long non-coding RNAs.

Authors:  Victoria E Villegas; Peter G Zaphiropoulos
Journal:  Int J Mol Sci       Date:  2015-02-03       Impact factor: 5.923

Review 10.  Long non-coding RNA-dependent transcriptional regulation in neuronal development and disease.

Authors:  Brian S Clark; Seth Blackshaw
Journal:  Front Genet       Date:  2014-06-06       Impact factor: 4.599

View more
  13 in total

1.  Novel mechanisms of regulation of the expression and transcriptional activity of hepatocyte nuclear factor 4α.

Authors:  Shangdong Guo; Hong Lu
Journal:  J Cell Biochem       Date:  2018-09-07       Impact factor: 4.429

Review 2.  Transcriptional and post-transcriptional regulation of the pregnane X receptor: a rationale for interindividual variability in drug metabolism.

Authors:  Tomas Smutny; Lucie Hyrsova; Albert Braeuning; Magnus Ingelman-Sundberg; Petr Pavek
Journal:  Arch Toxicol       Date:  2020-11-09       Impact factor: 5.153

3.  Knockdown of Long Noncoding RNAs Hepatocyte Nuclear Factor 1α Antisense RNA 1 and Hepatocyte Nuclear Factor 4α Antisense RNA 1 Alters Susceptibility of Acetaminophen-Induced Cytotoxicity in HepaRG Cells.

Authors:  Liming Chen; Pei Wang; José E Manautou; Xiao-Bo Zhong
Journal:  Mol Pharmacol       Date:  2020-02-06       Impact factor: 4.436

Review 4.  Advances and challenges in studying noncoding RNA regulation of drug metabolism and development of RNA therapeutics.

Authors:  Baitang Ning; Dianke Yu; Ai-Ming Yu
Journal:  Biochem Pharmacol       Date:  2019-09-10       Impact factor: 5.858

5.  Regulation of cytochrome P450 expression by microRNAs and long noncoding RNAs: Epigenetic mechanisms in environmental toxicology and carcinogenesis.

Authors:  Dongying Li; William H Tolleson; Dianke Yu; Si Chen; Lei Guo; Wenming Xiao; Weida Tong; Baitang Ning
Journal:  J Environ Sci Health C Environ Carcinog Ecotoxicol Rev       Date:  2019-07-15       Impact factor: 3.781

6.  Long noncoding RNA LINC00844-mediated molecular network regulates expression of drug metabolizing enzymes and nuclear receptors in human liver cells.

Authors:  Dongying Li; Leihong Wu; Bridgett Knox; Si Chen; William H Tolleson; Fang Liu; Dianke Yu; Lei Guo; Weida Tong; Baitang Ning
Journal:  Arch Toxicol       Date:  2020-03-28       Impact factor: 5.153

7.  Long Noncoding RNAs Hepatocyte Nuclear Factor 4A Antisense RNA 1 and Hepatocyte Nuclear Factor 1A Antisense RNA 1 Are Involved in Ritonavir-Induced Cytotoxicity in Hepatoma Cells.

Authors:  Xiaofei Wang; Yihang Yu; Pei Wang; Kun Yang; Yiting Wang; Liang Yan; Xiao-Bo Zhong; Lirong Zhang
Journal:  Drug Metab Dispos       Date:  2021-12-23       Impact factor: 3.579

8.  Genome-wide expression profiling reveals increased stability and mitochondrial energy metabolism of the human liver cell line HepaRG-CAR.

Authors:  Aziza A A Adam; Aldo Jongejan; Perry D Moerland; Vincent A van der Mark; Ronald P Oude Elferink; Robert A F M Chamuleau; Ruurdtje Hoekstra
Journal:  Cytotechnology       Date:  2020-03-04       Impact factor: 2.058

Review 9.  The Roles of Long Noncoding RNAs HNF1α-AS1 and HNF4α-AS1 in Drug Metabolism and Human Diseases.

Authors:  Liming Chen; Yifan Bao; Suzhen Jiang; Xiao-Bo Zhong
Journal:  Noncoding RNA       Date:  2020-06-24

10.  Alterations of Cytochrome P450-Mediated Drug Metabolism during Liver Repair and Regeneration after Acetaminophen-Induced Liver Injury in Mice.

Authors:  Yifan Bao; Mi Phan; Junjie Zhu; Xiaochao Ma; José E Manautou; Xiao-Bo Zhong
Journal:  Drug Metab Dispos       Date:  2021-08-04       Impact factor: 3.579

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.